Aug-2021 Recommendations to Mitigate CV Risk in Prostate Cancer
Speakers: Prof. Ricardo Rendon (Dalhousie University, Canada)
Cancer treatments have allowed patients to become survivors in the first place. However, cardiovascular cancer survivorship issues begin at the time of diagnosis, not years after completion of treatment. In his talk, Prof. Ricardo Rendon, the lead author of the recently published Canadian Urological Association guideline, will be focusing on ADT adverse events and management strategies, in which cardiometabolic health is extensively discussed.
